Cardiopulmonary bypass–mediated lung ischemia–reperfusion injury: A protective role of sitaxentan

Background Cardiopulmonary bypass is widely used in cardiac surgery but often leads to lung ischemia–reperfusion injury, a major cause of morbidity and mortality. Despite advances in critical care, effective prevention remains challenging. Sitaxentan, a selective endothelin receptor antagonist, has...

Full description

Bibliographic Details

Published in:	Journal of International Medical Research
Main Authors:	Zhengjia Wang, Renshu Zhan, Liqun Mo, Yingying Zhang, Yirong Chen, Li Liu, Yiping Bai
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-10-01
Online Access:	https://doi.org/10.1177/03000605251383318